This article is part of the supplement: Current perspectives on the treatment of rheumatic diseases with infliximab
How does infliximab work in rheumatoid arthritis?
-
* Corresponding author: Ravinder N Maini r.maini@ic.ac.uk
Arthritis Res 2002, 4(Suppl 2):S22-S28 doi:10.1186/ar549
Accesses
- Last 30 days: 200 accesses
- Last 365 days: 2065 accesses
- All time: 17943 accesses
Cited by
BioMed Central: 5 citations
|
Anti-tumour necrosis factor therapy and B cells in rheumatoid arthritis Maria J Leandro Arthritis Research & Therapy 2009, 11:128 (6 October 2009) |
|
M Margarida Souto-Carneiro, Vijayabhanu Mahadevan, Kazuki Takada, Ruth Fritsch-Stork, Toshihiro Nanki, Margaret Brown, Thomas A Fleisher, Mildred Wilson, Raphaela Goldbach-Mansky, Peter E Lipsky Arthritis Research & Therapy 2009, 11:R84 (5 June 2009) |
|
Effective use of TNF antagonists David Yocum Arthritis Res Ther 2004, 6(Suppl 2):S24-S30 (21 June 2004) |
|
Do anti-TNF agents have equal efficacy in patients with rheumatoid arthritis? Sergio Schwartzman, Roy Fleischmann, G James Morgan Arthritis Res Ther 2004, 6(Suppl 2):S3-S11 (21 June 2004) |
|
Current and new antitumor necrosis factor agents in perspective Ravinder N Maini Arthritis Res Ther 2004, 6(Suppl 2):S1-S2 (21 June 2004) |